Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2026-01-04 @ 9:00 AM
Study NCT ID:
NCT03301350
Status:
COMPLETED
Last Update Posted:
2023-02-01
First Post:
2017-09-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
Sponsor:
University of Wisconsin, Madison
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-29
First Submit QC Date:
None
Study First Post Date:
2017-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-10-14
Results First Submit QC Date:
None
Results First Post Date:
2023-02-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-09
Last Update Post Date:
2023-02-01
Last Update Post Date Type:
ACTUAL